Search

everythinglearnresearchcommunity

for

Search:↓

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Pumpkin seeds may improve health due to their rich nutrients and potential to treat various conditions.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Runx1 affects hair growth, cancer development, and autoimmune diseases in epithelial tissues.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

The term "porokeratotic adnexal ostial nevus" is proposed to unify overlapping skin conditions involving eccrine and hair follicles.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

More research needed to confirm finasteride as standard treatment for FFA.

Finasteride use may increase the risk of male breast cancer.

PLD is an effective and safer alternative for treating breast cancer.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

No definitive link between finasteride and male breast cancer, but further research is needed.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Understanding breast cancer requires considering both medical advancements and social influences.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.